Corporate Wellness Market to Grow at 6.9% CAGR Through 2035—Here’s What’s Driving It

The global corporate wellness market is witnessing robust expansion, driven by a surge in employee health awareness, technological advancements, and mounting healthcare costs. Valued at US$ 63.0 Bn in 2024, the market is projected to grow at a CAGR of 6.9%, reaching US$ 133.0 Bn by 2035, according to the latest market insights. This growth reflects a profound shift in how businesses approach employee well-being—transforming from reactive healthcare cost control to proactive wellness promotion.

Why Corporate Wellness Matters More Than Ever

In today’s fast-paced and digitally demanding work environments, stress, burnout, sedentary lifestyles, and chronic illnesses are taking a toll on employee health. Companies are increasingly aware of how these issues impact productivity, absenteeism, morale, and ultimately, business performance.

Organizations are now seeing employee wellness not just as a benefit, but as a strategic business priority. The shift is backed by data: According to the Centers for Disease Control and Prevention (CDC), employers save US$ 3.27 in medical costs and US$ 2.73 in productivity-related savings for every US$ 1 spent on wellness programs.

Digital Revolution Reshaping Corporate Wellness Delivery

A standout driver in the current landscape is the integration of digital health tools. Wearable devices, virtual coaching, mobile wellness apps, AI-based risk prediction, and cloud-based health dashboards are making wellness programs more accessible, scalable, and data-driven.

These tools not only support real-time health tracking but also enable customized wellness journeys. Employees can participate in guided workouts, access mental health support, and receive nutrition advice anytime, anywhere—an essential feature for hybrid and remote workforces.

Segment Insights: Health Risk Assessment Leading the Way

Among the various services offered, Health Risk Assessments (HRA) are leading the charge. This segment is expected to maintain a significant share due to its role in early disease detection and prevention. HRA programs evaluate employee health profiles, identify risk areas, and suggest personalized interventions, ultimately lowering long-term health costs and enhancing workplace vitality.

Other fast-growing services include:

Fitness programs promoting physical activity

Mental health counseling to combat stress and burnout

Smoking cessation programs

Weight management and nutritional guidance

Onsite vs. Offsite Wellness: A Blended Model for the Future

Wellness programs are delivered either onsite or offsite, with companies increasingly opting for hybrid models that offer flexibility. Onsite services such as yoga sessions, health screenings, and fitness classes are often paired with offsite or virtual support, giving employees 24/7 access to wellness resources.

This dual-delivery model allows for better engagement and program adherence, especially in global organizations with diverse work cultures and geographical footprints.

North America Dominates, but Global Opportunities Abound

North America continues to lead the global corporate wellness market in terms of revenue and adoption. High healthcare expenditures, employer-led health initiatives, and widespread use of digital health platforms are key contributors. The U.S. is at the forefront, with more than 73% of employers offering wellness programs in 2021—up from 58% in 2018.

However, emerging markets in Asia Pacific, Latin America, and the Middle East & Africa are displaying strong growth potential, spurred by rapid urbanization, rising chronic diseases, and growing corporate investments in employee health.

Challenges Ahead: Cost, Engagement, and Privacy

Despite impressive growth, the market faces hurdles. High upfront costs, especially for small and medium-sized businesses, can deter adoption. Low employee participation, a lack of management commitment, and data privacy concerns around health tracking technologies can also undermine program success.

Customization and clear communication about program benefits, combined with leadership support and robust data security, are essential to overcoming these barriers.

Key Players & Strategic Moves

Top companies are evolving from traditional wellness providers to integrated health partners, offering everything from biometric screenings to mental health apps.

Prominent market players include:

Optum, Inc. (UnitedHealth Group)

Cigna Healthcare

EXOS

ComPsych Corporation

Wellsource, Inc.

Truworth Wellness

Wellness Corporate Solutions

Recent developments show the pace of innovation:

Roga Life Inc. launched a wellness program aimed at combating workplace stress and burnout, following a successful beta.

Seva At Home, Inc. expanded its Seva PRO occupational health platform to include cardiac care and onsite medical services in early 2023.

The Future of Corporate Wellness: Personalized, Preventive, and Tech-Enabled

Looking ahead, the corporate wellness market is set to become more personalized, AI-integrated, and holistic. Programs will increasingly focus on mental resilience, chronic disease prevention, and behavioral health, alongside traditional fitness and nutrition components.

Moreover, wellness will move beyond perks to become an essential part of employer branding, talent retention, and workforce sustainability.

Conclusion

The corporate wellness market is no longer a niche offering—it’s a strategic imperative. As health becomes central to employee satisfaction and productivity, companies that prioritize well-being will not only cut healthcare costs but also attract and retain top talent. With the market set to double in value by 2035, now is the time for organizations to invest in smarter, more inclusive, and more engaging wellness strategies.

Review our report to gain deeper insights and understanding –

https://www.transparencymarketresearch.com/corporate-wellness-market.html

Read More

Tissue Sealants & Adhesives Market Trends Highlight Bio-based Product Preference and Technological Advancements

The global Tissue Sealants & Adhesives market is undergoing a remarkable transformation, driven by rapid advancements in bio-adhesive technologies and a growing emphasis on minimally invasive surgical procedures. Valued at approximately US$ 2.3 billion in 2024, this market is forecasted to nearly double over the next decade, reaching an estimated US$ 4.6 billion by 2035 with a compound annual growth rate (CAGR) of 6.4%. This dynamic growth highlights the critical role that tissue sealants and adhesives now play in modern medicine, particularly in complex surgeries where precise tissue bonding and effective hemostasis are paramount.

Understanding Tissue Sealants & Adhesives: What They Are and Why They Matter

Tissue sealants and adhesives are specialized medical products used to close wounds, control bleeding, and promote tissue healing by bonding biological surfaces. Unlike traditional closure methods such as sutures and staples, these products provide a less invasive, often faster alternative that can be critical in delicate or hard-to-reach areas of the body. Sealants create physical barriers to prevent fluid leakage, while adhesives chemically bond tissue surfaces to facilitate healing.

The applications span across numerous surgical specialties, including cardiovascular, orthopedic, neurosurgery, ophthalmic, gynecological, urological, and abdominal surgeries. These products also find use in trauma care and cosmetic procedures. The key differentiation in these products lies in their composition—natural sealants and adhesives are derived from biological substances like fibrin, collagen, and gelatin, while synthetic and semi-synthetic variants include cyanoacrylates and polyethylene glycols.

Natural sealants are particularly valued for their excellent biocompatibility and ability to promote faster healing and reduce postoperative complications. Synthetic options, while effective, sometimes pose a higher risk of adverse tissue reactions. This distinction underlines the rising preference for bio-adhesives in surgical settings.

Key Drivers Fueling Market Expansion

Rising Role of Bio-Adhesives in Surgical Bleeding Control

One of the most influential factors propelling the tissue sealants and adhesives market is the increasing reliance on bio-adhesives for controlling bleeding during surgeries. Bleeding control is critical, especially in cardiovascular and orthopedic surgeries, where precision and rapid hemostasis can drastically influence patient outcomes. Bio-adhesives, being naturally derived from proteins and polysaccharides, offer superior tissue compatibility and sealing properties, enabling surgeons to achieve effective closure and reduce risks such as infections and excessive blood loss.

This has resulted in bio-adhesives becoming an indispensable tool in modern operating rooms, particularly with the global healthcare sector’s focus on improving surgical safety and efficiency. Additionally, innovations have led to bio-adhesive formulations with enhanced antimicrobial properties, further lowering postoperative infection rates and complications.

Growing Awareness and Adoption of Advanced Wound Care Solutions

Healthcare providers and patients alike are becoming more aware of advanced wound care technologies that improve healing times, minimize scarring, and enhance comfort compared to conventional wound closure techniques. This awareness is shifting clinical practice towards the adoption of tissue sealants and adhesives that provide rapid and reliable wound closure, particularly in ambulatory surgical centers and hospital settings.

The rising patient preference for minimally invasive procedures with shorter recovery times and fewer complications is also boosting demand. Healthcare systems worldwide are responding by investing in innovative wound care products that align with these patient-centric goals.

Market Segmentation: Product, Application, and End-user

Natural Sealants and Adhesives Lead the Product Segment

Within the product landscape, natural sealants and adhesives dominate the market due to their superior biocompatibility and regenerative potential. Derived from fibrin, collagen, gelatin, and other biological materials, these products have been particularly successful in high-precision surgeries such as cardiovascular and orthopedic procedures. Their ability to closely mimic natural tissue behavior reduces adverse immune responses and fosters faster healing.

Recent advances in biotechnology have further enhanced the effectiveness of these natural sealants by improving their hemostatic capabilities and supporting tissue regeneration. These improvements have encouraged surgeons and healthcare providers to increasingly prefer natural bio-adhesives over synthetic alternatives.

Diverse Surgical Applications

The demand for tissue sealants and adhesives spans multiple surgical disciplines. Cardiovascular and orthopedic surgeries are prominent application areas due to the complex nature of these procedures and the critical need for efficient bleeding control. Neurosurgery, ophthalmic surgery, gynecological and urological surgery, as well as abdominal surgeries, are also significant contributors to market demand. Each specialty requires specific adhesive properties and formulations tailored to tissue type and surgical conditions, which has led to the development of a wide variety of products catering to these diverse needs.

End-users: Hospitals and Ambulatory Surgical Centers

Hospitals represent the largest end-user segment, given the high volume of surgeries and availability of advanced surgical infrastructure. Ambulatory surgical centers (ASCs) are emerging as important end-users as they increasingly adopt minimally invasive procedures that benefit from tissue sealants and adhesives. The convenience, reduced recovery time, and lower infection risk associated with these products make them ideal for outpatient settings as well.

Regional Market Insights: North America Leading Innovation

North America currently holds the largest share of the global tissue sealants and adhesives market. The region’s advanced healthcare infrastructure, strong investment in medical R&D, and presence of leading medical device companies drive early adoption and innovation in this space. The high prevalence of chronic diseases requiring surgical intervention, such as cardiovascular and orthopedic conditions, further propels demand.

Regulatory support and well-established approval pathways in the region also facilitate faster commercialization of new and improved products. Additionally, increasing healthcare expenditure and focus on improving surgical outcomes ensure that North America maintains its leadership role in this sector.

Other regions, including Europe and Asia Pacific, are also showing strong growth potential. Investments in healthcare infrastructure and rising awareness of advanced wound care solutions in emerging markets contribute to the expanding global footprint of tissue sealants and adhesives.

Competitive Landscape and Key Industry Developments

The tissue sealants and adhesives market is characterized by intense competition among leading global players. Companies such as Advanced Medical Solutions Group plc, Baxter, Stryker, Johnson & Johnson (Ethicon), Artivion, BD, Medtronic, and others are continuously innovating to expand product portfolios and enhance performance.

Recent noteworthy developments include Johnson & Johnson’s Ethicon division launching Ethizia, a hemostatic sealing patch designed for effective bleeding control in surgeries. Advanced Medical Solutions Group plc’s acquisition of Connexicon Medical Limited, a company specializing in tissue adhesive technologies, reflects the ongoing strategic efforts to bolster technological capabilities and market reach.

These companies focus on advancing product formulations to achieve faster hemostasis, enhanced biocompatibility, antimicrobial effects, and regenerative properties, ensuring they remain competitive while addressing evolving clinical needs.

Conclusion: A Promising Future for Tissue Sealants & Adhesives

The Tissue Sealants & Adhesives Market is set for substantial growth over the next decade, fueled by technological innovation, increasing surgical volumes, and the growing shift toward minimally invasive procedures. Bio-adhesives, with their superior safety and efficacy profiles, are at the forefront of this expansion, transforming surgical care by enabling better outcomes and faster patient recovery.

As healthcare systems globally continue to prioritize patient safety and operational efficiency, the demand for advanced tissue sealants and adhesives will only intensify. Stakeholders from manufacturers to healthcare providers must stay attuned to emerging trends and breakthroughs to capitalize on this evolving market.

Gain in-depth knowledge by accessing our full report -

https://www.transparencymarketresearch.com/tissue-sealants-and-adhesives-market.html 

Read More

Oncology Information System (OIS) Market Insights Reveal Increasing Investment in Personalized Cancer Care

The global Oncology Information System (OIS) market is poised for robust growth, expected to more than double from a valuation of US$ 3.3 billion in 2024 to US$ 7.1 billion by 2035, according to a new market research report. Growing at a healthy compound annual growth rate (CAGR) of 7.2% between 2025 and 2035, the market is driven by the increasing global burden of cancer and the critical need for streamlined data management across oncology care domains.

The rising incidence of cancer worldwide—nearly 20 million new cases and close to 10 million deaths recorded in 2022 alone—is placing unprecedented pressure on healthcare providers to deliver timely, accurate, and personalized oncology care. Oncology Information Systems are emerging as indispensable tools that unify patient data, automate treatment planning, and facilitate real-time monitoring in medical, radiation, and surgical oncology.

Advancements in AI, Cloud Platforms, and Interoperability Transform Market Landscape
The shift towards precision oncology and AI-driven treatments is accelerating demand for sophisticated OIS platforms capable of integrating molecular profiling, genomic data, and predictive analytics. Cloud-based delivery models enhance scalability and remote access, while interoperability with electronic health records (EHR) and imaging systems is becoming a standard feature, enabling multidisciplinary care coordination.

North America leads the global market, supported by advanced healthcare IT infrastructure, government-backed precision medicine initiatives, and high adoption rates of digital oncology platforms. The U.S., in particular, is home to numerous National Cancer Institute-designated cancer centers utilizing AI-enabled OIS to improve treatment planning and patient surveillance.

Meanwhile, the Asia Pacific region is witnessing rapid market expansion fueled by healthcare digitization investments and rising cancer prevalence. Europe remains committed to integrating automation and combined care models in oncology, with key players like Elekta, Varian (Siemens Healthineers), and Cerner spearheading innovation through AI and strategic partnerships.

Software Solutions Dominate, Enabling Multidisciplinary Care and Enhanced Outcomes
Software solutions, including patient information systems and treatment planning systems, dominate the OIS market due to their pivotal role in managing complex oncology workflows. Platforms such as Elekta’s MOSAIQ offer unified environments that enhance clinical coordination and improve patient outcomes by centralizing treatment data and analytics.

Key Industry Players Drive Innovation and Strategic Collaborations
Market leaders—including Varian Medical Systems, Elekta, Philips Healthcare, Cerner, Epic Systems, Siemens Healthineers, and others—are actively investing in technological advancements and strategic partnerships to expand their oncology solution portfolios. Notable recent developments include Siemens Healthineers’ acquisition of Varian Medical Systems in 2021 and Philips’ collaboration with Elekta to enhance precision oncology care.

Oncology Information System Market Snapshot:

Market Size (2024): US$ 3.3 billion

 

Forecast Size (2035): US$ 7.1 billion

 

CAGR (2025-2035): 7.2%

 

Key Segments: Software (Patient Information Systems, Treatment Planning Systems), Services

 

Applications: Medical Oncology, Radiation Oncology, Surgical Oncology

 

Leading Region: North America, followed by Asia Pacific and Europe

Visit our report to explore the detailed insights and key takeaways –

https://www.transparencymarketresearch.com/oncology-information-system-market.html 

Read More

Surgical Lasers Market Forecast: Solid-State and Diode Lasers Lead Technological Shift

 

The global surgical lasers market was valued at US$ 3.2 Bn in 2024 and is projected to grow at a CAGR of 6.3% from 2025 to 2035, reaching more than US$ 6.2 Bn by 2035, according to a comprehensive market report published by Transparency Market Research. Technological advancements, growing preference for minimally invasive procedures, and increasing demand in cosmetic and aesthetic applications are expected to fuel market growth in the coming years.

Analysts’ Viewpoint

The surgical lasers market is expected to expand steadily due to increasing prevalence of chronic diseases, rising demand for precision-based surgical procedures, and favorable growth in emerging markets. Technological innovations in solid-state and diode laser systems are widening the scope of application across multiple specialties such as ophthalmology, dermatology, gynecology, and ENT.

Despite high upfront costs and regulatory complexities, increasing investment in healthcare infrastructure and demand for outpatient procedures in ambulatory surgery centers (ASCs) are expected to create significant growth opportunities for manufacturers and service providers in this domain.

Surgical Lasers Market Overview

Surgical lasers utilize concentrated light energy for cutting, vaporizing, or coagulating tissue, offering advantages such as minimal bleeding, reduced recovery time, and improved patient outcomes. These lasers are integrated in various specialties including ophthalmology, dermatology, dentistry, urology, oncology, and gynecology. The market encompasses various laser types such as solid-state lasers, gas lasers, and diode lasers.

Key Market Drivers

1. Technological Advancements in Laser Systems:
Breakthroughs in diode, femtosecond, and fiber laser technologies have led to improved precision, safety, and efficiency in surgical procedures. These innovations are expanding the adoption of laser systems across newer therapeutic areas.

2. Rising Demand for Cosmetic and Aesthetic Procedures:
Increased consumer preference for non-invasive aesthetic treatments such as skin resurfacing, wrinkle reduction, tattoo removal, and scar revision is boosting demand for laser-based devices, particularly in dermatology and plastic surgery.

3. Growth in Chronic Disease Burden and Geriatric Population:
The increasing number of patients requiring surgical interventions for chronic diseases such as cancer, glaucoma, cardiovascular conditions, and benign prostatic hyperplasia is propelling the market for advanced surgical technologies.

Segment Insights

Laser Type:
The solid-state lasers segment accounted for a dominant share of the market in 2024 and is expected to continue leading during the forecast period. These lasers, including Nd:YAG, Ho:YAG, and Erbium-doped fiber lasers, offer enhanced precision and versatility in procedures across ophthalmology, urology, and oncology.

Application:
Among applications, dermatology and ophthalmology emerged as key revenue-generating segments, owing to widespread use in cosmetic procedures and laser-assisted vision correction. The urology and ENT segments are also witnessing robust adoption of laser systems due to minimally invasive benefits and reduced complications.

End-user:
Hospitals remain the leading end-user segment, driven by their superior infrastructure, multidisciplinary surgical capabilities, and high patient inflow. Increasing surgical volumes and greater access to capital equipment funding further reinforce hospitals' leading market position.

Regional Outlook

North America held the largest share of the global market in 2024 and is expected to maintain its dominance during the forecast period. Advanced healthcare infrastructure, high adoption of medical technologies, favorable reimbursement policies, and a strong presence of key players contribute to regional growth.
Asia Pacific is projected to be the fastest-growing market, attributed to rising medical tourism, growing disposable income, and increasing demand for cosmetic surgeries and outpatient procedures in China, India, and ASEAN countries.

Competitive Landscape

Key players operating in the global surgical lasers market include:

• Carl Zeiss Meditec AG

• Medtronic

• Alcon

• Boston Scientific Corporation

• Cynosure

• Candela Corporation

• STAAR Surgical

• Fotona

• Sciton

• Bison Medical

• Coherent Corp.

• KLS Martin Group

• JenaSurgical

These companies are focused on product innovation, strategic partnerships, and expansion in emerging markets to enhance their market presence.

Recent Developments

• July 2024: ViaLase, Inc. received CE Mark approval in the EU for its ViaLase Laser targeting adult patients with primary open-angle glaucoma.

• December 2024: FemtoVox Incorporated entered into a development agreement with Mayo Clinic to commercialize femtosecond laser technologies for ENT surgeries, focusing initially on laryngeal interventions.

Market Segmentation

By Laser Type:

• Solid-State Lasers

  • Nd:YAG Lasers

  • Ho:YAG Lasers

  • Erbium-Doped Fiber Lasers

  • Ti:Sapphire Lasers

• Gas Lasers

  • CO₂ Lasers

  • Excimer Gases

  • Argon, Helium-Neon

• Diode Lasers

• Others

By Application:

• Ophthalmology

• Dermatology

• Dentistry

• Gynecology

• Urology

• Oncology

• Cardiology

• ENT

• Others

By End-user:

• Hospitals

• Ambulatory Surgery Centers

• Specialty Clinics

• Others

By Region:

• North America (U.S., Canada)

• Europe (Germany, U.K., France, Italy, Spain)

• Asia Pacific (China, India, Japan, Australia & New Zealand)

• Latin America (Brazil, Mexico)

• Middle East & Africa (GCC, South Africa)

Access detailed insights by visiting our full report -

https://www.transparencymarketresearch.com/surgical-lasers-market.html 

Read More

Intrauterine Devices Market Competitive Landscape: Key Players Focus on Expanding Access Through Clinics

The global intrauterine devices (IUDs) market is set for significant growth, with projections indicating an increase from US$ 4.7 billion in 2024 to more than US$ 14.2 billion by 2035. This growth trajectory, driven by a robust compound annual growth rate (CAGR) of 10.6%, highlights the increasing demand for long-acting reversible contraception (LARC) options and growing public awareness around family planning and women’s health.

Market Overview

IUDs are a popular form of contraception due to their convenience, effectiveness, and long-term usage potential. These devices, which are inserted into the uterus by healthcare providers, can prevent pregnancy for up to 10 years or more, depending on the type. There are two major types of IUDs: copper IUDs and hormonal (levonorgestrel) IUDs. Both types consist of a plastic frame that adopts a T-shape once inserted, providing highly effective birth control without the need for daily user action.

The rise in contraceptive awareness, enhanced by public health campaigns and governmental family planning initiatives, is a key factor fueling the growth of the IUD market. Furthermore, advancements in product technology, such as IUDs incorporating shape memory alloy components to prevent complications like misplacement or uterine perforation, are attracting increasing demand from women seeking reliable and safe long-term birth control options.

Analyst Insights

"Intrauterine devices have long been a trusted option for women seeking effective, long-term contraception," said [Analyst Name], Lead Market Analyst at [Company]. "With increasing awareness of the multiple benefits of IUDs—ranging from preventing pregnancy to alleviating menstrual pain and reducing menstrual bleeding—there is a surge in demand for both copper and hormonal IUDs globally. This is further supported by government-backed initiatives aimed at reducing unintended pregnancies and expanding access to healthcare, particularly in underserved regions."

Key Drivers of Market Growth

• Rising Awareness Among Women: Increasing education about the benefits of IUDs is driving greater adoption. As women gain more access to information about the advantages of IUDs over short-acting contraceptives, acceptance rates are rising across various age groups and geographical regions.

• Government Initiatives: Numerous government programs designed to improve access to contraception, reduce unwanted pregnancies, and decrease abortion rates are playing a pivotal role in expanding the global IUD market. International organizations, such as the World Health Organization (WHO), are also supporting the widespread distribution of IUDs, particularly in rural and underserved communities.

• Technological Advancements: The latest advancements in IUD technology, including low-dose hormone-free copper IUDs and products that minimize insertion-related discomfort, are boosting market demand. A notable example is Sebela Pharmaceuticals’ next-generation Copper 175 mm² IUD, which showed a remarkable 99% efficacy in a 2023 Phase 3 study.

Market Segmentation

The market is segmented into several key categories, including:

• By Product Type:

  • Copper IUDs

  • Hormonal (levonorgestrel) IUDs
    Hormonal IUDs dominate the market due to their additional benefits, such as reduced menstrual bleeding and relief from menstrual cramps.

• By Age Group:

  • 15-20

  • 21-34

  • 35-44

  • 45+

• By End-User:

  • Hospitals

  • Gynecology Clinics

  • Community Health Care Centers

Regional Analysis

North America leads the global market for IUDs, driven by strong awareness, supportive government policies, and healthcare systems that facilitate access to these contraceptive devices. The U.S. is a key contributor, with national programs such as Title X and the Affordable Care Act improving access to affordable contraceptive options.

The Asia Pacific region is expected to witness significant growth, driven by a large female population, increasing awareness, and expanding access to reproductive health services.

Key Players in the Market

The intrauterine devices market features several prominent players, including:

• AbbVie

• Bayer AG

• CooperSurgical Inc.

• DKT INTERNATIONAL

• EUROGINE, S.L.

• Mona Lisa N.V.

• OCON Medical Ltd.

• Pregna International Limited

• Prosan International BV

• SMB Corporation of India

These companies are focusing on expanding their market presence through strategic partnerships with hospitals, gynecology clinics, and community health centers to enhance distribution and availability of IUDs globally.

Recent Developments

In January 2025, 49Care launched Yanae, a new copper IUD featuring a flexible inserter designed to make insertion easier and less painful. This innovative product will be available in Canadian pharmacies starting January 15, 2025, at a competitive price of US$ 140, which is comparable to older copper IUD models but offers superior ease of use.

Conclusion

The intrauterine devices market is expected to see robust growth over the next decade, driven by increasing awareness, government initiatives, and innovations in product technology. As IUDs continue to gain popularity as a highly effective and convenient long-term contraceptive option, market stakeholders are well-positioned to capitalize on the expanding demand for reproductive health products globally.

Unlock comprehensive insights by visiting our detailed report -

https://www.transparencymarketresearch.com/intrauterine-devices-market.html 

Read More